Inogen (INGN)
(Real Time Quote from BATS)
$8.43 USD
+0.20 (2.43%)
Updated Jun 6, 2024 03:50 PM ET
After-Market: $8.45 +0.02 (0.24%) 4:08 PM ET
2-Buy of 5 2
C Value A Growth D Momentum B VGM
Brokerage Reports
0 items in cart
Inogen, Inc [INGN]
Reports for Purchase
Showing records 1 - 20 ( 284 total )
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Optimized Entry and Exit Levels for INGN 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Medical Technology: Suspending Coverage of 21 Companies
Provider: KeyBanc Capital Markets
Analyst: Research Department